Market Exclusive

ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH) Files An 8-K Results of Operations and Financial Condition

ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH) Files An 8-K Results of Operations and Financial Condition

Item2.02

RESULTS OF OPERATIONS AND FINANCIAL
CONDITION

On January10, 2017, Zimmer Biomet Holdings, Inc. (the Registrant)
issued a press release announcing its preliminary fourth quarter
and full-year 2016 sales results. The press release is attached
as Exhibit99.1 and the information set forth therein is
incorporated herein by reference and constitutes a part of this
report.

The Registrant is furnishing the information contained in this
report, including the Exhibit, to Item2.02 of Form 8-K
promulgated by the Securities and Exchange Commission (the SEC).
This information shall not be deemed to be filed with the SEC or
incorporated by reference into any other filing with the SEC. By
filing this report on Form 8-K and furnishing this information,
the Registrant makes no admission as to the materiality of any
information in this report, including the Exhibit.


Item9.01
FINANCIAL STATEMENTS AND EXHIBITS


(d)
Exhibits


Exhibit No.


Description

99.1 Press Release, dated January10, 2017, issued by the
Registrant

About ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH)
Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc., is engaged designing, manufacturing and marketing orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company’s products and solutions helps treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consists of the United States and includes other North, Central and South American markets; EMEA, consists of Europe and includes the Middle East and African markets, and Asia Pacific, consists of Japan and includes other Asian and Pacific markets. Its four product category segments include Americas Spine, Bone Healing Craniomaxillofacial and Thoracic, and Dental. ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH) Recent Trading Information
ZIMMER BIOMET HOLDINGS, INC. (NYSE:ZBH) closed its last trading session 00.00 at 107.00 with 1,163,298 shares trading hands.

Exit mobile version